Infosheet


Pre-commercial procurement and public procurement of innovation

Public buyers invest in innovative solutions in order to respond to the more and more complex challenges and also to boost innovation. The main procedures in this respect are Pre-commercial procurement (PCP) & Public procurement of innovation (PPI).

Programmes Horizon Europe HorizonEU L+F

Published on | 3 years ago

Last updated on | 4 weeks ago

Author Do you have an additional question? Or spotted a mistake? Don't hesitate to contact me!
Image of Pascal Verheye
Pascal Verheye

pascal.verheye@vlaio.be

Contracting authorities have decided to invest more money in developing and buying innovative products and services to respond to increasingly complex challenges and to pull innovation from the market. The main procedures in this so-called Innovation Procurement are Pre-commercial procurement (PCP) & Public procurement of innovation (PPI).

About PCP

PCP as the first step in innovation procurement starts from relatively low technology readiness levels (TRLs). The public buyer purchases R&D services for a product or a service that is still further away from the market. PCP is divided in three phases: solution design (TRL 3-4), prototype development (TRL 5-6) and original development of a limited volume of first products/services (TRL 7-8).

At least two competitors are needed in every phase of PCP and the general principles of equal treatment, proportionality and transparency apply. As there is a clear separation between the procurement of R&D and the deployment of commercial volumes of end-products, PCP does not fall under the scope of the European Procurement Directive. The main guiding document for PCP is the Commission Communication COM(2007)799 final.

About PPI

PPI comes into the picture when the solution is almost on the market or already on the market in small quantities (TRL 9) so the public buyer purchases innovative solutions that are not yet available on a large-scale commercial basis. In quantified terms it means the public contractor must be an early adopter or one of the first 20% buyers to enter the market. PPI is regulated by the European Public Procurement Directive.

PCP & PPI in Horizon Europe

As investments in innovative procurement are generally lower than other parts of the world, the European Commission has set up an ambitious PPI/PCP strategy spread out over different EU programmes. One of the programmes involved is Horizon Europe.

In Horizon Europe, the funding rates for PCP calls and related activities is maximum 100% while for PPI calls this is 50%.

If you want more information on this topic, you can also watch the webinar about PCP/PPI in Horizon Europe on Youtube and you can also visit the dedicated webpage of the European Commission. Of course the NCP team is also there to help you so do not hesitate to send an email to marie.timmermann@fwo.be

In Flanders there is a linked PCP/PPI programma called “Innovatief Aanbesteden” which tries to link up with these calls and can give you more general advice on how to approach a PCP/PPI call. You can contact their director by mail: veerle.lories@vlaanderen.be.

 

myOVERVIEW
- sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Testimonial

image of SAPHIRe - Securing the Adoption of Personalised Medicin in Regions

SAPHIRe - Securing the Adoption of Personalised Medicin in Regions

The Department of Economy, Science and Innovation of the Flemish government coordinates the Horizon 2020 Coordination and Support Action SAPHIRe, which started on 1 December 2018. The aim of the project is to secure the adoption of personalised medicine in all European regions, including sparsely populated and remote regions and regions with different innovation capacities. 

The activities of SAPHIRe are complementary to the smart specialisation partnership on personalised medicine – S3P4PM, which is also coordinated by the Department of Economy, Science and Innovation.